Pharming Group Nv Stock Investor Sentiment

PHGUF Stock  USD 0.75  0.07  8.54%   
Roughly 62% of Pharming Group's investor base is looking to short. The analysis of overall sentiment of trading Pharming Group NV pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Pharming Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharming Group NV stock news signals to limit their universe of possible portfolio assets.
Pharming Group pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharming daily returns and investor perception about the current price of Pharming Group NV as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Pharming Group Sees Strong Trading Volume - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group announces the launch of an offering of approximately 100 million convertible bonds du...
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Sees Strong Trading Volume - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Joenjas Journey Navigating the Market Risks and Regulatory Challenges Post-Approval for Pharming Gro...
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group announces the filing of its 2023 Annual Report and Form 20-F - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023 - The Globe and Mail
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Shares Gap Up to 11.00 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Sees Unusually-High Trading Volume - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group N.V. Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Is Pharming Group N V ADS each representing 10 Ord Shs Stock Worth a Buy Friday - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Analyst Reiterates Buy Rating for Pharming Group with 37 Price Target - Best Stocks
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Sees Large Volume Increase - AmericanBankingNEWS
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group Shares Gap Down to 11.75 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group versus Agios Pharmaceuticals Financial Review - AmericanBankingNEWS
Google News at Macroaxis
over six months ago at news.google.com         
Pharming Group issues full-year 2023 guidance - Seeking Alpha
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharming Group that are available to investors today. That information is available publicly through Pharming media outlets and privately through word of mouth or via Pharming internal channels. However, regardless of the origin, that massive amount of Pharming data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharming Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharming Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharming Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharming Group alpha.

Pharming Group Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharming Pink Sheet analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios